With what the management has achieved over 5 years is remarkable.
From my experience with new medical inovation start ups that require regulatory approval to be used, it is a road less traveled.
When Brian Leadman started his vision of Resapp dx comparing it to a Star Trek Tricorder as used by his favorite character Bones the Enterprises Medical Officer...
I though about that today..so I looked at a YouTube interview of Brian Leadman.
I love the bit when he talks about where Prof Abeyratane first started research capturing cough sounds to diagnose respiratory illness funded by Gates Foundation and done....oh I love this.. In Indonesia ...great video
And now 4 years from this interview...Resapp dx had Indonesian Regulatory approval and is being used by one of the largest and well respected Telehealth platforms ALODOKTOR in Indonesia ...
I find this to be amazing.
At the time of this interview the shares were hovering around 30+ cents...
The massive potential is with Alodokter PING Medgate Doctor's on Demand in Australia Europe India and USA
As a Medical Clinician I knew this would be big...
I believe if Resapp dx gets 1000 uses out of 20,000 consults a day...
That's over $500,000 in revenue for next quarter...
And I see Medgate bringing $300,000
this quarter..
So my guestimate for 4th quarter revenue is $1.5 million
All my opinion
Resapphealth 2022, page-63
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #